News

  • Metastasis Research Society 20th Biennial Congress, 2024

    July 04, 2024
    This year's Metastasis Research Society Biennial Congress was held from June 23-25, 2024 in London, United Kingdom. Our MSc student, Harjot Athwal, attended and presented her latest findings in a poster entitled, "Anticancer Effects of Radiation Therapy and CFI-400945 in Triple Negative Breast Cancer (TNBC)"

  • Oncology Research and Education Day, London ON, 2024

    June 13, 2024
    Oncology Research and Education Day, 2024. The Parsyan lab presented exciting new data with Dr. Parsyan giving an oral presentation and trainees presenting their findings in poster sessions.

  • Dr. Robert Zhong Department of Surgery Research Day, London ON, 2024

    June 05, 2024
    Dr. Robert Zhong Department of Surgery Research Day, 2024. Dr. Parsyan gave a presentation, "Spatial Omics Studies in Breast Cancer – New Opportunities for Biomarker and Drug Target Discoveries", highlighting our most recent findings in spatial omics analysis of TNBC patient samples.

  • New Grant Funding: AMOSO Clinical Innovation Fund Award

    April 05, 2024
    Academic Medical Organization of Southwestern Ontario (AMOSO)'s Clinical Innovation Fund Award. The project is entitiled, “Spatial Omics for Novel Prognostic and Neoadjuvant Chemotherapy Response Biomarkers Discovery in Triple-Negative Breast Cancer"

  • Meet the Researcher: Harjot Athwal

    January 03, 2024
    Harjot explains her research project and how it brings us closer to understanding the ways in which treatments might be combined to create a better outcome for TNBC breast cancer patients

  • Bringing Two Worlds Together

    June 30, 2020
    The road to becoming a clinician-scientist was long and winding, but Dr. Armen Parsyan never gave up. Now at Schulich Medicine & Dentistry, he is making major strides in translating breast cancer research into practice.

  • New Hope for the 1 in 8

    January 17, 2020
    LHSC introduces Dr. Parsyan as part of their effort to recruit breast cancer physicians and researchers to improve our understanding, advance our approach to therapy and improve patient care to those battling breast cancer.